Asparlas OverviewCalaspargase pegol-mknl (trade name Asparlas) is a drug for the treatment of acute lymphoblastic leukemia (ALL). It is approved by the Food and Drug Administration for use in the United States as a component of a multi-agent chemotherapeutic regimen for ALL in pediatric and young adult patients aged 1 month to 21 years. Calaspargase pegol is an engineered protein consisting of the E. coli-derived enzyme L-asparaginase II conjugated with succinimidyl carbonate monomethoxypo...
Read more Asparlas Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Calaspargase_pegol-mknl
Recent Asparlas Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 3750units/5ml
NDC Database Records for Asparlas: (1 result)Sorted by National Drug Code
- 72694-515 Asparlas 750 U/Ml Intravenous Injection, Solution by Servier Pharmaceuticals LLC